ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer

March 22, 1985

Duke Picks Lyerly To Direct Cancer Center

May 2, 2003